This presentation was part of the 2021 clinical symposia, Radiotherapy for Benign Conditions. See Dr. Ogawa’s presentation below from the second session, Radiotherapy for Hyperproliferative Disorders.
Xstrahl to Spotlight Superficial and Orthovoltage Radiotherapy Solutions for Skin Cancer and Benign Conditions at ESTRO 2024
Xstrahl, a global leader in the delivery of superficial radiation therapy devices and preclinical radiation research systems, will demonstrate Xstrahl 200, a modern orthovoltage radiotherapy solution for treating superficial lesions, skin cancers, and selective benign conditions at the European Society for Radiotherapy and Oncology (ESTRO) Annual Meeting in Glasgow, UK, May 3-7, 2024, stand # 1070.
